PMID- 29174244 OWN - NLM STAT- MEDLINE DCOM- 20180716 LR - 20181202 IS - 2213-3763 (Electronic) IS - 0019-4832 (Print) IS - 0019-4832 (Linking) VI - 69 IP - 6 DP - 2017 Nov-Dec TI - Left ventricular global longitudinal strain following revascularization in acute ST elevation myocardial infarction - A comparison of primary angioplasty and Streptokinase-based pharmacoinvasive strategy. PG - 695-699 LID - S0019-4832(17)30044-5 [pii] LID - 10.1016/j.ihj.2017.04.010 [doi] AB - OBJECTIVE: Tenecteplase-based pharmacoinvasive percutaneous coronary intervention (PCI) has been shown to yield outcomes comparable to primary PCI in the setting of acute ST elevation myocardial infarction (STEMI). This study was designed to compare the efficacy of pharmacoinvasive PCI following successful thrombolysis with Streptokinase versus primary PCI in patients with STEMI. METHODOLOGY: We conducted a prospective single center observational study in 120 patients with STEMI who underwent primary PCI (n=60) and Streptokinase-based pharmacoinvasive PCI (n=60). Patients with Killips class 3 or 4 at presentation, and those with evidence of failed fibrinolysis were excluded. The primary outcome was LV systolic function after angioplasty, as assessed by 2D global longitudinal strain (GLS) using speckle tracking echocardiography (STE), as well as 2D LVEF using Simpson's biplane method. RESULTS: LV systolic function after PCI was significantly lower in the pharmacoinvasive arm as compared to the primary PCI arm, both by 2D STE (GLS: -9% vs -11%; p=0.03) and 2D Simpson's biplane method (LVEF: 40.7% vs 45.1%; p=0.02). TIMI flow in the culprit vessel prior to angioplasty was better in the pharmacoinvasive arm indicating successful thrombolysis, whereas post angioplasty flow was not different. There was no in-hospital mortality in either group. There was a trend toward increased incidence of acute kidney injury in the pharmacoinvasive arm. CONCLUSION: LV systolic function is significantly better after primary angioplasty as compared to pharmacoinvasive PCI following successful thrombolysis with Streptokinase. CI - Copyright (c) 2017. Published by Elsevier B.V. FAU - Paul, Amal AU - Paul A AD - Department of Cardiology, Christian Medical College Vellore, Tamilnadu 632004, India. Electronic address: look_lama@yahoo.co.in. FAU - George, Paul V AU - George PV AD - Department of Cardiology, Christian Medical College Vellore, Tamilnadu 632004, India. Electronic address: pvg@cmcvellore.ac.in. LA - eng PT - Comparative Study PT - Journal Article PT - Observational Study DEP - 20170509 PL - India TA - Indian Heart J JT - Indian heart journal JID - 0374675 RN - 0 (Fibrinolytic Agents) RN - EC 3.4.21.68 (Tissue Plasminogen Activator) RN - WGD229O42W (Tenecteplase) SB - IM MH - Echocardiography MH - Electrocardiography MH - Female MH - Fibrinolytic Agents/therapeutic use MH - Follow-Up Studies MH - Heart Ventricles/diagnostic imaging/*physiopathology MH - Humans MH - Male MH - Middle Aged MH - *Percutaneous Coronary Intervention MH - Prospective Studies MH - ST Elevation Myocardial Infarction/diagnosis/*physiopathology/therapy MH - Tenecteplase MH - Thrombolytic Therapy/*methods MH - Tissue Plasminogen Activator/*therapeutic use MH - Ventricular Function, Left/*physiology PMC - PMC5717277 OTO - NOTNLM OT - Global longitudinal strain (GLS) OT - Pharmacoinvasive PCI OT - Primary PCI OT - Streptokinase EDAT- 2017/11/28 06:00 MHDA- 2018/07/17 06:00 PMCR- 2018/11/01 CRDT- 2017/11/28 06:00 PHST- 2017/01/22 00:00 [received] PHST- 2017/04/09 00:00 [revised] PHST- 2017/04/17 00:00 [accepted] PHST- 2017/11/28 06:00 [entrez] PHST- 2017/11/28 06:00 [pubmed] PHST- 2018/07/17 06:00 [medline] PHST- 2018/11/01 00:00 [pmc-release] AID - S0019-4832(17)30044-5 [pii] AID - 10.1016/j.ihj.2017.04.010 [doi] PST - ppublish SO - Indian Heart J. 2017 Nov-Dec;69(6):695-699. doi: 10.1016/j.ihj.2017.04.010. Epub 2017 May 9.